.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Citi
Express Scripts
Cerilliant
Queensland Health
Boehringer Ingelheim
Mallinckrodt
Medtronic
Deloitte
Federal Trade Commission

Generated: June 22, 2017

DrugPatentWatch Database Preview

Metaproterenol sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for metaproterenol sulfate and what is the scope of metaproterenol sulfate patent protection?

Metaproterenol sulfate
is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Apotex Inc, Wockhardt, Mylan Speciality Lp, DEY, Usl Pharma, Watson Labs, Astrazeneca, Teva, Muro, Par Pharm, Nephron, Silarx, G And W Labs Inc, Am Therap, and Morton Grove, and is included in thirty-six NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for metaproterenol sulfate. Two suppliers are listed for this compound.

Summary for Generic Name: metaproterenol sulfate

Tradenames:3
Patents:1
Applicants:16
NDAs:36
Drug Master File Entries: see list6
Suppliers / Packagers: see list2
Bulk Api Vendors: see list51
Clinical Trials: see list634
Patent Applications: see list7,386
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:metaproterenol sulfate at DailyMed

Pharmacology for Ingredient: metaproterenol sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Muro
PROMETA
metaproterenol sulfate
SOLUTION;INHALATION073340-001Mar 30, 1992DISCNNoNo► Subscribe► Subscribe
Watson Labs
METAPROTERENOL SULFATE
metaproterenol sulfate
TABLET;ORAL073013-001Jan 31, 1991DISCNNoNo► Subscribe► Subscribe
Par Pharm
METAPROTERENOL SULFATE
metaproterenol sulfate
TABLET;ORAL072024-001Jun 28, 1988RXNoNo► Subscribe► Subscribe
Wockhardt
METAPROTERENOL SULFATE
metaproterenol sulfate
SOLUTION;INHALATION075586-002May 30, 2002DISCNNoNo► Subscribe► Subscribe
Dey
METAPROTERENOL SULFATE
metaproterenol sulfate
SOLUTION;INHALATION071806-001Aug 5, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: metaproterenol sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
ALUPENT
metaproterenol sulfate
SYRUP;ORAL017571-001Approved Prior to Jan 1, 19823,422,196► Subscribe
Boehringer Ingelheim
ALUPENT
metaproterenol sulfate
TABLET;ORAL015874-001Approved Prior to Jan 1, 19823,422,196► Subscribe
Boehringer Ingelheim
ALUPENT
metaproterenol sulfate
AEROSOL, METERED;INHALATION016402-001Approved Prior to Jan 1, 19823,422,196► Subscribe
Boehringer Ingelheim
ALUPENT
metaproterenol sulfate
TABLET;ORAL015874-002Approved Prior to Jan 1, 19823,422,196► Subscribe
Boehringer Ingelheim
ALUPENT
metaproterenol sulfate
SOLUTION;INHALATION018761-001Jun 30, 19833,422,196► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Cerilliant
Merck
Fuji
Healthtrust
Deloitte
UBS
Julphar
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot